INDOUS80.34

Indo Us Biotech Limited

· FMCG & Retail
AnnualQuarterly₹ CrorePeersKOHINOORNATHBIOGENAGRITECHSARVESHWARSUKHJITSREGAALBSHSLGULPOLYMcap ₹161 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY25
30/09/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations22.233.430.861.622.826.033.0
Other Income0.00.10.00.00.00.00.1
Total Income22.233.530.861.622.826.033.1
Expenses
+ Cost of Materials Consumed11.130.88.828.315.634.48.6
+ Purchases of Stock-in-Trade0.120.17.27.720.33.15.2
+ Changes in Inventories3.3-26.56.19.8-20.0-19.112.2
+ Employee Benefit Expense0.20.30.30.70.30.40.3
+ Finance Costs0.50.30.50.90.80.60.7
+ Depreciation & Amortisation0.20.60.20.40.20.30.3
+ Other Expenses2.34.12.95.52.33.92.7
Total Expenses17.729.626.053.319.623.730.0
EBITDA5.14.65.59.64.23.24.0
EBIT4.94.05.39.23.93.03.7
Profit
PBT before Exceptional Items4.43.94.88.43.22.43.1
Pretax Income4.43.94.88.43.22.43.1
+ Current Tax0.00.30.10.20.10.30.0
+ Deferred Tax0.1-0.10.00.10.00.1-0.0
Tax Expense0.10.20.10.20.20.40.0
Net Income4.43.74.78.23.02.03.0
+ Net Income — Continuing Ops4.43.74.78.23.02.03.0
+ Other Comprehensive Income-0.00.00.0-0.0-0.0-0.00.0
Total Comprehensive Income4.33.74.78.23.02.03.0
Per Share
Basic EPS2.161.862.354.061.490.981.51
Diluted EPS2.161.862.354.061.490.981.51
Other Comprehensive Income — detail
+ Other Comprehensive Income0.00.0-0.0-0.0-0.00.0
+ Tax on Items NOT to be Reclassified-0.00.0-0.00.00.00.0
+ Tax on Items NOT to be Reclassified — alt tag0.0
+ Tax on Items to be Reclassified0.0-0.00.0-0.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations2.161.862.354.061.490.981.51
Diluted EPS — Continuing Operations2.161.862.354.061.490.981.51
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period57,056.83,10,862.35,54,047.9
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit7.69.08.615.76.87.67.0
Gross Margin %34.4926.8828.1025.5529.9029.2321.10
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)4.43.94.88.43.22.43.1
Net Income Adj (tax-effected)4.43.74.78.23.02.03.0
EPS Adj2.161.862.354.061.490.981.51
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.0010.0010.00
Paid Up Equity Capital20.120.120.120.120.120.120.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.